Join us at The Pendry Hotel, San Diego
Friday, April 17 • 6:00 PM - 9:00 PM PST • Grand Ballroom 3 & 4
A special symposium on the state of MRD detection research
Gathering leaders in oncology research from around the globe for an engaging discussion on the utility of novel sequencing technology to improve cancer prognosis and treatment.
Registration will open at 5:30 PM and dinner will be served starting at 6:00 PM, with a networking happy hour immediately following the program.
Meeting Co-Chairs
Plenary • 6:35 - 7:20 PM
Program Talks
Panel Discussion I • 7:25 - 8:00 PM
MRD In solid tumors: from detection to clinical action
Panel Discussion II • 8:05 - 8:45 PM
Beyond detection: using ctDNA in clinical trials to monitor therapy and understand resistance
Detailed Agenda
| Time | Speaker/Session | Talk Title |
|---|---|---|
| 5:30 PM | Registration opens | |
| 6:00 PM - 7:30 PM | Dinner & refreshments | |
| 6:30 PM - 6:35 PM | Opening remarks | |
| 6:35 PM - 6:50 PM | ||
| 6:50 PM - 7:05 PM | Yuval Dor, PhD | Ultra-sensitive brain epigenetic liquid biopsy |
| 7:05 PM - 7:20 PM | Jonathan C. M. Wan, MD, PhD | Error-corrected plasma whole-genome sequencing for personalized and tumor-agnostic minimal residual disease detection in NSCLC |
| 7:25 PM - 8:00 PM | Panel Discussion I | MRD in solid tumors: from detection to clinical action |
| 8:05 PM - 8:45 PM | Panel Discussion II | Beyond detection: using ctDNA in clinical trials to monitor therapy and understand resistance |
| 8:45 PM - 10:00 PM | Drinks & networking |